- Home
- AUPH vs STEW Comparison
AUPH vs STEW Comparison
Compare AUPH & STEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AUPH | STEW |
|---|---|---|
| Founded | 1993 | N/A |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.7B |
| IPO Year | 2014 | 1996 |
Fundamental Metrics
Financial Performance| Metric | AUPH | STEW |
|---|---|---|
| Price | $15.60 | $17.25 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $17.25 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 73.3K |
| Earning Date | 05-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 5075.00 | N/A |
| EPS | ★ 2.07 | N/A |
| Revenue | ★ $283,055,000.00 | N/A |
| Revenue This Year | $16.53 | N/A |
| Revenue Next Year | $16.24 | N/A |
| P/E Ratio | $7.48 | ★ N/A |
| Revenue Growth | ★ 20.38 | N/A |
| 52 Week Low | $6.83 | $15.00 |
| 52 Week High | $16.54 | $18.67 |
Technical Indicators
Market Signals| Indicator | AUPH | STEW |
|---|---|---|
| Relative Strength Index (RSI) | 63.33 | 49.65 |
| Support Level | $14.56 | N/A |
| Resistance Level | $16.28 | $18.34 |
| Average True Range (ATR) | 0.52 | 0.24 |
| MACD | 0.15 | 0.05 |
| Stochastic Oscillator | 99.72 | 81.25 |
Price Performance
Historical ComparisonAbout AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About STEW SRH Total Return Fund Inc.
SRH Total Return Fund, Inc. is a non-diversified closed-end management investment company. The company's investment objective is to seek total returns. Its fund utilizes a bottom-up, value-driven investment process to identify securities of good quality businesses trading below estimated intrinsic value. The Funds are available as an actively-managed closed-end fund, an actively managed ETF and a passively-managed ETF.